Report cover image

Squalene Market by Source (Animal, Vegetable, and Synthetic Biotechnology), End Use Industry (Cosmetics, Nutraceuticals, and Healthcare): Global Opportunity Analysis and Industry Forecast, 2021–2030

Publisher Allied Market Research
Published Feb 18, 2022
Length 221 Pages
SKU # ALMR17117534

Description

Squalene Market by Source (Animal, Vegetable, and Synthetic Biotechnology), End Use Industry (Cosmetics, Nutraceuticals, and Healthcare): Global Opportunity Analysis and Industry Forecast, 2021–2030

The global squalene market was valued at $114.5 million in 2020, and is projected to reach $241.6 million by 2030, growing at a CAGR of 7.8% from 2021 to 2030.

Squalene is a natural oily liquid hydrocarbon found in plants and animals. It is commonly found in large quantities in animal oil. It is the most common lipids produced by human skin cells, making up approximately 10% of our sebum. It is widely used as chemo-preventive agent, antioxidant, and immune system restorer in cosmetics, medical, nutraceuticals, and other end use sectors.

Rise in disposable income and awareness for hygiene and personal grooming activities has increased demand for various cosmetic products where squalene is widely used in creams and lotions to increase their absorption and spreadability. This is expected to aggressively penetrate and boost demand for squalene in the growing cosmetics industry. In addition, increasing severity of diseases has led to rise in growth of the healthcare sector where squalene is used as antioxidant and immune system restorer in various medicines and food supplements. This factor positively drive growth of the squalene market.

However, stringent rules and regulations imposed by several wildlife protection agencies to stop animal killings may moderately impact production of squalene from various animals. This hampers growth of the squalene market during the forecast period.

On the contrary, rise in R&D activities has led to potential applications of squalene in various end use sectors. For instance, laboratory studies have confirmed that squalene enhances function of macrophages that makes it suitable to be used as a prime immune booster ingredient. Furthermore, it exhibits anti-viral, anti-fungal, and anti-bacterial properties that make it suitable for use in pharmaceutical sector. This is anticipated to increase in sales of squalene in several end use sectors; thus creating lucrative opportunities for the market.

The global squalene market analysis is done on the basis of source, end use industry, and region. Depending on source, the market is divided into animal, vegetable, and synthetic biotechnology. On the basis of end use industry, it is fragmented into cosmetics, nutraceuticals, and healthcare. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global squalene market profiles leading players that include Amyris, Inc., ARISTA INDUSTRIES INC, Empresa Figueirense De Pesca, Lda, Gracefruit Limited, Kshimoto Special Liver Oil Co., LTD., New Zealand Green Health Ltd, NUCELIS LLC, Otto Chemie Pvt. Ltd., SEADRAGON MARINE OILS LIMITED, and SOPHIM IBERIA S.L.

The global squalene market report provides in-depth competitive analysis as well as profiles of these major players.

1.1. Key benefits for stakeholders

Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
It outlines the current trends and future estimations of the market from 2020 to 2030 to understand the prevailing opportunities and potential investment pockets.
The major countries in the region have been mapped according to their individual revenue contribution to the regional market.
The key drivers, restraints, and opportunities and their detailed impact analysis are explained in the study.
The profiles of key players and their key strategic developments are enlisted in the report.

1.2. Key market segments

By Source

Animal
Vegetable
Synthetic Biotechnology

By End use industry

Cosmetics
Nutraceuticals
Healthcare

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Turkey
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
UAE
Argentina
Rest of LAMEA

Key players in the global squalene market are:

1. Amyris, Inc.
2. ARISTA INDUSTRIES INC
3. Empresa Figueirense De Pesca, Lda
4. Gracefruit Limited
5. Kshimoto Special Liver Oil Co., LTD.
6. New Zealand Green Health Ltd
7. NUCELIS LLC
8. Otto Chemie Pvt. Ltd.
9. SEADRAGON MARINE OILS LIMITED
10. SOPHIM IBERIA S.L

Table of Contents

221 Pages
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.5.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Growth of cosmetics industry
3.4.1.2.Increase in value and potential of dietary supplements
3.4.1.3.Squalene as a chemo-preventive agent
3.4.2.Restraint
3.4.2.1.Government rules and regulations
3.4.3.Opportunity
3.4.3.1.Squalene as an anti-oxidant and immune system support
3.5.Value chain analysis
3.6.Pricing analysis
3.7.Impact of key regulations on the global squalene market
3.8.Impact of COVID-19 on the global squalene market
3.9.Patent analysis, 2012–2021
CHAPTER 4:SQUALENE MARKET, BY SOURCE
4.1.Overview
4.1.1.Market size and forecast, by source
4.2.Animal
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country
4.3.Vegetable
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country
4.4.Synthetic biotechnology
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country
CHAPTER 5:SQUALENE MARKET, BY END USE INDUSTRY
5.1.Overview
5.1.1.Market size and forecast
5.2.Cosmetics
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.Nutraceuticals
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.4.Healthcare
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
CHAPTER 6:SQUALENE MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by source
6.2.3.Market size and forecast, by end use industry
6.2.4.Market share analysis, by country
6.2.4.1.U.S.
6.2.4.1.1.Market size and forecast, by source
6.2.4.1.2.Market size and forecast, by end use industry
6.2.4.2.Canada
6.2.4.2.1.Market size and forecast, by source
6.2.4.2.2.Market size and forecast, by end use industry
6.2.4.3.Mexico
6.2.4.3.1.Market size and forecast, by source
6.2.4.3.2.Market size and forecast, by end use industry
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by source
6.3.3.Market size and forecast, by end use industry
6.3.4.Market size and forecast, by country
6.3.4.1.Germany
6.3.4.1.1.Market size and forecast, by source
6.3.4.1.2.Market size and forecast, by end use industry
6.3.4.2.UK
6.3.4.2.1.Market size and forecast, by source
6.3.4.2.2.Market size and forecast, by end use industry
6.3.4.3.France
6.3.4.3.1.Market size and forecast, by source
6.3.4.3.2.Market size and forecast, by end use industry
6.3.4.4.Spain
6.3.4.4.1.Market size and forecast, by source
6.3.4.4.2.Market size and forecast, by end use industry
6.3.4.5.Turkey
6.3.4.5.1.Market size and forecast, by source
6.3.4.5.2.Market size and forecast, by end use industry
6.3.4.6.Rest of Europe
6.3.4.6.1.Market size and forecast, by source
6.3.4.6.2.Market size and forecast, by end use industry
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by source
6.4.3.Market size and forecast, by end use industry
6.4.4.Market size and forecast, by country
6.4.4.1.China
6.4.4.1.1.Market size and forecast, by source
6.4.4.1.2.Market size and forecast, by end use industry
6.4.4.2.Japan
6.4.4.2.1.Market size and forecast, by source
6.4.4.2.2.Market size and forecast, by end use industry
6.4.4.3.India
6.4.4.3.1.Market size and forecast, by source
6.4.4.3.2.Market size and forecast, by end use industry
6.4.4.4.South Korea
6.4.4.4.1.Market size and forecast, by source
6.4.4.4.2.Market size and forecast, by end use industry
6.4.4.5.Rest of Asia-Pacific
6.4.4.5.1.Market size and forecast, by source
6.4.4.5.2.Market size and forecast, by end use industry
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by source
6.5.3.Market size and forecast, by end use industry
6.5.4.Market size and forecast, by country
6.5.4.1.Brazil
6.5.4.1.1.Market size and forecast, by source
6.5.4.1.2.Market size and forecast, by end use industry
6.5.4.2.Saudi Arabia
6.5.4.2.1.Market size and forecast, by source
6.5.4.2.2.Market size and forecast, by end use industry
6.5.4.3.UAE
6.5.4.3.1.Market size and forecast, by source
6.5.4.3.2.Market size and forecast, by end use industry
6.5.4.4.Argentina
6.5.4.4.1.Market size and forecast, by source
6.5.4.4.2.Market size and forecast, by end use industry
6.5.4.5.Rest of LAMEA
6.5.4.5.1.Market size and forecast, by source
6.5.4.5.2.Market size and forecast, by end use industry
CHAPTER 7:COMPETITIVE LANDSCAPE
7.1.INTRODUCTION
7.1.1.MARKET PLAYER POSITIONING, 2020
7.2.PRODUCT MAPPING OF TOP 10 PLAYER
7.3.COMPETITIVE DASHBOARD
7.4.COMPETITIVE HEATMAP
CHAPTER 8:COMPANY PROFILES
8.1.AMYRIS INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Product portfolio
8.1.4.Business performance
8.2.ARISTA INDUSTRIES INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.3.EMPRESA FIGUEIRENSE DE PESCA, LDA
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Product portfolio
8.4.GRACEFRUIT LIMITED
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.5.Kshimoto special liver oil co., ltd
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.6.New Zealand Green Health Ltd.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product Portfolio
8.7.NUCELIS LLC
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Product portfolio
8.8.Otto Chemie Pvt. Ltd.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Product portfolio
8.9.SEADRAGON MARINE OILS LIMITED
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Business performance
8.10.SOPHIM IBERIA S.L.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Product portfolio
LIST OF TABLES
TABLE 01.SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)62
TABLE 02.SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)63
TABLE 03.SQUALENE MARKET FOR ANIMAL, BY REGION, 2020–2030 ($MILLION)65
TABLE 04.SQUALENE MARKET FOR ANIMAL, BY REGION, 2020–2030 (TONS)66
TABLE 05.SQUALENE MARKET FOR VEGETABLE, BY REGION, 2020–2030 ($MILLION)70
TABLE 06.SQUALENE MARKET FOR VEGETABLE, BY REGION, 2020–2030 (TONS)71
TABLE 07.SQUALENE MARKET FOR SYNTHETIC BIOTECHNOLOGY, BY REGION, 2020–2030 ($MILLION)73
TABLE 08.SQUALENE MARKET FOR SYNTHETIC BIOTECHNOLOGY, BY REGION, 2020–2030 (TONS)74
TABLE 09.SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)77
TABLE 10.SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)77
TABLE 11.SQUALENE MARKET FOR COSMETICS, BY REGION, 2020–2030 ($MILLION)80
TABLE 12.SQUALENE MARKET FOR COSMETICS, BY REGION, 2020–2030 (TONS)80
TABLE 13.SQUALENE MARKET FOR NUTRACEUTICALS, BY REGION, 2020–2030 ($MILLION)84
TABLE 14.SQUALENE MARKET FOR NUTRACEUTICALS, BY REGION, 2020–2030 (TONS)85
TABLE 15.SQUALENE MARKET FOR HEALTHCARE END USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)87
TABLE 16.SQUALENE MARKET FOR HEALTHCARE END USE INDUSTRY, BY REGION, 2020–2030 (TONS)88
TABLE 17.SQUALENE MARKET, BY REGION, 2020–2030 ($MILLION)92
TABLE 18.SQUALENE MARKET, BY REGION, 2020–2030 (TONS)93
TABLE 19.NORTH AMERICA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)95
TABLE 20.NORTH AMERICA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)97
TABLE 21.NORTH AMERICA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)98
TABLE 22.NORTH AMERICA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)98
TABLE 23.NORTH AMERICA SQUALENE MARKET, BY COUNTRY, 2020–2030 ($MILLION)100
TABLE 24.NORTH AMERICA SQUALENE MARKET, BY COUNTRY, 2020–2030 (TONS)100
TABLE 25.U.S. SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)102
TABLE 26.U.S. SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)103
TABLE 27.U.S. SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)104
TABLE 28.U.S. SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)104
TABLE 29.CANADA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)106
TABLE 30.CANADA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)108
TABLE 31.CANADA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)109
TABLE 32.CANADA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)109
TABLE 33.MEXICO SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)111
TABLE 34.MEXICO SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)113
TABLE 35.MEXICO SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)114
TABLE 36.MEXICO SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)114
TABLE 37.EUROPE SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)116
TABLE 38.EUROPE SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)117
TABLE 39.EUROPE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)118
TABLE 40.EUROPE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)119
TABLE 41.EUROPE SQUALENE MARKET, BY COUNTRY, 2020–2030 ($MILLION)120
TABLE 42.EUROPE SQUALENE MARKET, BY COUNTRY, 2020–2030 (TONS)121
TABLE 43.GERMANY SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)123
TABLE 44.GERMANY SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)125
TABLE 45.GERMANY SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)125
TABLE 46.GERMANY SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)126
TABLE 47.U.K. SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)128
TABLE 48.U.K. SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)130
TABLE 49.U.K. SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)131
TABLE 50.U.K. SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)131
TABLE 51.FRANCE SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)132
TABLE 52.FRANCE SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)133
TABLE 53.FRANCE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)134
TABLE 54.FRANCE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)135
TABLE 55.SPAIN SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)136
TABLE 56.SPAIN SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)137
TABLE 57.SPAIN SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)138
TABLE 58.SPAIN SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)138
TABLE 59.TURKEY SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)140
TABLE 60.TURKEY SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)140
TABLE 61.TURKEY SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)141
TABLE 62.TURKEY SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)142
TABLE 63.REST OF EUROPE SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)143
TABLE 64.REST OF EUROPE SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)145
TABLE 65.REST OF EUROPE OPTICALLY 3.4 CLEAR ADHESIVES MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)146
TABLE 66.REST OF EUROPE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)146
TABLE 67.ASIA-PACIFIC SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)148
TABLE 68.ASIA-PACIFIC SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)149
TABLE 69.ASIA-PACIFIC SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)150
TABLE 70.ASIA-PACIFIC SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)150
TABLE 71.ASIA-PACIFIC SQUALENE MARKET, BY COUNTRY, 2020–2030 ($MILLION)151
TABLE 72.ASIA-PACIFIC SQUALENE MARKET, BY COUNTRY, 2020–2030 (TONS)152
TABLE 73.CHINA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)154
TABLE 74.CHINA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)154
TABLE 75.CHINA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)155
TABLE 76.CHINA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)156
TABLE 77.JAPAN SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)157
TABLE 78.JAPAN SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)159
TABLE 79.JAPAN SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)160
TABLE 80.JAPAN SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)160
TABLE 81.INDIA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)161
TABLE 82.INDIA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)162
TABLE 83.INDIA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)163
TABLE 84.INDIA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)163
TABLE 85.SOUTH KOREA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)165
TABLE 86.SOUTH KOREA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)165
TABLE 87.SOUTH KOREA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)166
TABLE 88.SOUTH KOREA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)167
TABLE 89.REST OF ASIA-PACIFIC SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)168
TABLE 90.REST OF ASIA-PACIFIC SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)169
TABLE 91.REST OF ASIA-PACIFIC SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)170
TABLE 92.REST OF ASIA-PACIFIC SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)170
TABLE 93.LAMEA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)171
TABLE 94.LAMEA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)172
TABLE 95.LAMEA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)173
TABLE 96.LAMEA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)173
TABLE 97.LAMEA SQUALENE MARKET, BY COUNTRY, 2020–2030 ($MILLION)175
TABLE 98.LAMEA SQUALENE MARKET, BY COUNTRY, 2020–2030 (TONS)175
TABLE 99.BRAZIL SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)177
TABLE 100.BRAZIL SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)179
TABLE 101.BRAZIL SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)179
TABLE 102.BRAZIL SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)180
TABLE 103.SAUDI ARABIA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)181
TABLE 104.SAUDI ARABIA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)182
TABLE 105.SAUDI ARABIA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)183
TABLE 106.SAUDI ARABIA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)183
TABLE 107.UAE SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)185
TABLE 108.UAE SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)187
TABLE 109.UAE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)187
TABLE 110.UAE SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)188
TABLE 111.ARGENTINA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)189
TABLE 112.ARGENTINA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)190
TABLE 113.ARGENTINA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)191
TABLE 114.ARGENTINA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)191
TABLE 115.REST OF LAMEA SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)192
TABLE 116.REST OF LAMEA SQUALENE MARKET, BY SOURCE, 2020–2030 (TONS)193
TABLE 117.REST OF LAMEA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)194
TABLE 118.REST OF LAMEA SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 (TONS)194
TABLE 119.AMYRIS INC.: COMPANY SNAPSHOT201
TABLE 120.AMYRIS INC..: PRODUCT PORTFOLIO202
TABLE 121.AMYRIS INC.:OVERALL FINANCIAL STATUS ($MILLION)203
TABLE 122.ARISTA INDUSTRIES INC: COMPANY SNAPSHOT205
TABLE 123.ARISTA INDUSTRIES INC.: PRODUCT PORTFOLIO205
TABLE 124.EMPRESA FIGUEIRENSE DE PESCA, LDA: COMPANY SNAPSHOT206
TABLE 125.EMPRESA FIGUEIRENSE DE PESCA, LDA.: PRODUCT PORTFOLIO207
TABLE 126.GRACEFRUIT LIMITED: COMPANY SNAPSHOT208
TABLE 127.GRACEFRUIT LIMITED:PRODUCT PORTFOLIO208
TABLE 128.KSHIMOTO SPECIAL LIVER OIL CO., LTD.: COMPANY SNAPSHOT209
TABLE 129.KSHIMOTO SPECIAL LIVER OIL CO., LTD.: PRODUCT PORTFOLIO210
TABLE 130.NEW ZEALAND GREEN HEALTH LTD.:COMPANY SNAPSHOT211
TABLE 131.NEW ZEALAND GREEN HEALTH LTD.: PRODUCT PORTFOLIO211
TABLE 132.NUCELIS LLC.: COMPANY SNAPSHOT212
TABLE 133.NUCELIS LLC .: PRODUCT PORTFOLIO212
TABLE 134.OTTO CHEMIE PVT. LTD.: COMPANY SNAPSHOT213
TABLE 135.OTTO CHEMIE PVT. LTD.: PRODUCT PORTFOLIO214
TABLE 136.SEADRAGON MARINE OILS LIMITED: COMPANY SNAPSHOT214
TABLE 137.SEADRAGON MARINE OILS LIMITED: PRODUCT PORTFOLIO215
TABLE 138.SEADRAGON MARINE OILS LIMITE:OVERALL FINANCIAL STATUS ($MILLION)216
TABLE 139.SOPHIM IBERIA S.L..: COMPANY SNAPSHOT217
TABLE 140.SOPHIM IBERIA S.L.: PRODUCT PORTFOLIO217
LIST OF FIGURES
FIGURE 01.SQUALENE MARKET SNAPSHOT39
FIGURE 02.SQUALENE MARKET SEGMENTATION42
FIGURE 03.TOP INVESTMENT POCKETS44
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS45
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS47
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS48
FIGURE 07.MODERATE THREAT OF SUBSTITUTES49
FIGURE 08.MODERATE COMPETITIVE RIVALRY50
FIGURE 09.SQUALENE MARKET DYNAMICS51
FIGURE 10.VALUE CHAIN ANALYSIS54
FIGURE 11.SQUALENE MARKET, PRICING ANALYSIS, BY PRODUCT SOURCE, USD/TONS55
FIGURE 12.PATENT ANALYSIS, BY COUNTRY, 202158
FIGURE 13.PATENT ANALYSIS, BY APPLICANT, 202159
FIGURE 14.PATENT ANALYSIS, BY PUBLICATION DATE, 2012–202160
FIGURE 15.SQUALENE MARKET, BY SOURCE, 2020–2030 ($MILLION)61
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR ANIMAL, BY COUNTRY, 2020 & 2030 (%)68
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR VEGETABLE, BY COUNTRY, 2020 & 2030 (%)71
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR SYNTHETIC BIOTECHNOLOGY, BY COUNTRY, 2020 & 2030 (%)75
FIGURE 19.SQUALENE MARKET, BY END USE INDUSTRY, 2020–2030 ($MILLION)76
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR COSMETICS, BY COUNTRY, 2020 & 2030 (%)82
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR NUTRACEUTICALS, BY COUNTRY, 2020 & 2030 (%)86
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SQUALENE MARKET FOR HEALTHCARE, BY COUNTRY, 2020& 2030 (%)90
FIGURE 23.SQUALENE MARKET, BY REGION, 2020–2030 ($MILLION)91
FIGURE 24.U.S. SQUALENE MARKET REVENUE, 2020–2030($MILLION)101
FIGURE 25.CANADA SQUALENE MARKET REVENUE, 2020–2030($MILLION)106
FIGURE 26.MEXICO SQUALENE MARKET REVENUE, 2020–2030($MILLION)111
FIGURE 27.GERMANY SQUALENE MARKET REVENUE, 2020–2030($MILLION)123
FIGURE 28.UK SQUALENE MARKET REVENUE, 2020–2030($MILLION)128
FIGURE 29.FRANCE SQUALENE MARKET REVENUE, 2020–2030($MILLION)132
FIGURE 30.SPAIN SQUALENE MARKET REVENUE, 2020–2030($MILLION)135
FIGURE 31.TURKEY SQUALENE MARKET REVENUE, 2020–2030($MILLION)139
FIGURE 32.REST OF EUROPE SQUALENE MARKET REVENUE, 2020–2030($MILLION)143
FIGURE 33.CHINA SQUALENE MARKET REVENUE, 2020–2030($MILLION)153
FIGURE 34.JAPAN SQUALENE MARKET REVENUE, 2020–2030($MILLION)157
FIGURE 35.INDIA SQUALENE MARKET REVENUE, 2020–2030($MILLION)161
FIGURE 36.SOUTH KOREA SQUALENE MARKET REVENUE, 2020–2030($MILLION)164
FIGURE 37.REST OF ASIA-PACIFIC SQUALENE MARKET REVENUE, 2020–2030($MILLION)167
FIGURE 38.BRAZIL SQUALENE MARKET REVENUE, 2020–2030($MILLION)177
FIGURE 39.SAUDI ARABIA SQUALENE MARKET REVENUE, 2020–2030 ($MILLION)181
FIGURE 40.UAE SQUALENE MARKET REVENUE, 2020–2030($MILLION)185
FIGURE 41.ARGENTINA MARKET REVENUE, 2020–2030($MILLION)189
FIGURE 42.REST OF LAMEA MARKET REVENUE, 2020–2030($MILLION)192
FIGURE 43.MARKET PLAYER POSITIONING, 2020197
FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS198
FIGURE 45.COMPETITIVE DASHBOARD.199
FIGURE 46.COMPETITIVE HEATMAP OF KEY PLAYERS200
FIGURE 47.AMYRIS INC.: REVENUE, 2018–2020 ($MILLION)203
FIGURE 48.AMYRIS INC.: REVENUE SHARE BY REGION, 2020 (%)204
FIGURE 49.SEADRAGON MARINE OILS LIMITED: REVENUE, 2018–2020 ($MILLION)215

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us